OKYO Pharma Limited (OKYO:NASDAQ) closed at $1.43 on October 14, 2026, down 0.88% on the day. The stock trades 55.5% below its 52-week high of $3.20 and 12.6% above its 52-week low of $1.27. Over the past year, it lost 26.3%. OKYO Pharma Limited is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| +1.24% | +2.69% | +4.17% | -13.40% | -26.28% |
In 252 trading sessions since October 13, 2025, OKYO closed higher on 107 days (42%). Its best day was January 9, 2026 (+18.97%) and its worst was February 13, 2026 (-19.35%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 2 times.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions on various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
Find more stocks like OKYO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.